Skip to main navigation

> Main Menu

About Our Company Our History Corporate Values Leadership Team Mission Work Corporate Transparency

Products

Careers

Contact

Investors Overview News Events Letters to Stockholders Corporate Transparency Report Corporate Governance SEC Filings & Financials Stock Information Investor Resources

> Main Menu

About

Our Company Our History Corporate Values Leadership Team Mission Work Corporate Transparency

Products Careers Contact

Investors

Overview News Events Letters to Stockholders Corporate Transparency Report Corporate Governance SEC Filings & Financials Stock Information Investor Resources

Press Releases

Year

November 20, 2024

Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery

November 15, 2024

Harrow Announces Participation in Upcoming Investor Conferences

November 13, 2024

Harrow Announces Third Quarter 2024 Financial Results

November 13, 2024

Harrow Launches Access and Affordability Program with Price Reductions for Branded Products

November 12, 2024

Harrow Announces Market Access Wins for VEVYE®

November 7, 2024

Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products

October 31, 2024

Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024

October 10, 2024

Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery

October 3, 2024

Harrow Relaunches TRIESENCE®

September 25, 2024

Harrow Announces Nashville Expansion

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 29

Address

1A Burton Hills Blvd., Suite 200
Nashville, TN 37215

Phone

(615) 733 4730
(615) 733 4737 (Investor Relations)

Social

Copyright © 2024 Harrow, Inc. All rights reserved.

> Footer

Privacy Policy Terms of Use Cookie Notice